D. Western Therapeutics Institute (TSE:4576) EPS (Basic): 円-6.81 (TTM As of Dec. 2025)


TSE:4576 D. Western Therapeutics Institute Inc TSE:4576
51 GF Score
Price 円69.00
GF Value 円64.35
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is D. Western Therapeutics Institute EPS (Basic)?

D. Western Therapeutics Institute TSE:4576 -1.43% 51 EPS (Basic) is 円-6.81 as of Dec. 2025. GuruFocus rates TSE:4576 with a GF Score™ of 51/100 and a GF Value™ of 円64.35 (Fairly Valued). The stock has 3 warning signs investors should review.

D. Western Therapeutics Institute's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was 円0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was 円-6.81.

D. Western Therapeutics Institute's EPS (Diluted) for the three months ended in Dec. 2025 was 円0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円-6.81.

D. Western Therapeutics Institute's EPS without NRI for the three months ended in Dec. 2025 was 円0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -6.81.

During the past 3 years, the average EPS without NRI Growth Rate was -7.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -25.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, D. Western Therapeutics Institute's highest 3-Year average EPS without NRI Growth Rate was 43.60% per year. The lowest was -91.00% per year. And the median was 2.10% per year.

D. Western Therapeutics Institute  (TSE:4576) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

D. Western Therapeutics Institute EPS (Basic) Related Terms

D. Western Therapeutics Institute EPS (Basic) Historical Data

* Premium members only.

The historical data trend for D. Western Therapeutics Institute's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D. Western Therapeutics Institute EPS (Basic) Chart

D. Western Therapeutics Institute Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.08 -14.50 -25.56 -36.74 -13.19

D. Western Therapeutics Institute Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -3.41 -3.67 0.00 -3.14
TSE:4576
51GF Score
D. Western Therapeutics Institute Inc TSE:4576
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

D. Western Therapeutics Institute EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

D. Western Therapeutics Institute's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-632.087-0)/47.928
=-13.19

D. Western Therapeutics Institute's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0-0)/47.928
=0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-6.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of 円-6.81 mean?
D. Western Therapeutics Institute (TSE:4576) has a EPS (Basic) of 円-6.81 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's EPS (Basic) too high?
D. Western Therapeutics Institute's current EPS (Basic) is 円-6.81. Overall, D. Western Therapeutics Institute has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's EPS (Basic) compare to VRTX and REGN?
D. Western Therapeutics Institute's EPS (Basic) of 円-6.81 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current EPS (Basic) is 円-6.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Fairly Valued. The stock's GF Value™ is 円64.35, compared to a current price of 円69.00 — trading 7.2% above its estimated fair value. The current EPS (Basic) is 円-6.81. D. Western Therapeutics Institute's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current EPS (Basic) is 円-6.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?

Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued. The current stock price of 円69.00 is trading 7.2% above its estimated GF Value™ of 円64.35. GuruFocus considers D. Western Therapeutics Institute to be Fairly Valued.

Key valuation signals for TSE:4576:

  • EPS (Basic): 円-6.81
  • GF Value™: 円64.35 vs. price of 円69.00 (7.2% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D. Western Therapeutics Institute Business Description

Other Exchanges 6DW:Germany
Address 7th Floor, 18 KT Bulding, 1-18-11, Nishiki, Naka-ku, Aichi, Nagoyashi, JPN, 460-0003
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
51GF Score

Get the complete analysis for TSE:4576

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円69.00
Price
円64.35
GF Value